InnaVirVax Strengthens Patent Protection of VAC-3S Immunotherapy

News   Dec 26, 2012

 
InnaVirVax Strengthens Patent Protection of VAC-3S Immunotherapy
 
 
 
 

RELATED ARTICLES

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

READ MORE

CRISPR Reveals New Targets for Promising Cancer Drugs

News

Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.

READ MORE

New Way Found to Boost Immunity in Fighting Cancer and Infections

News

Researchers have identified a key new mechanism that regulates the ability of T-cells of the immune system to react against foreign antigens and cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE